official impact factor

4.36

Advanced search

This article is part of the supplement: Current and new antitumor necrosis factor agents in perspective

Does route of administration affect the outcome of TNF antagonist therapy?

Sergio Schwartzman^* and G James Morgan

* Corresponding author: Sergio Schwartzman schwartzmans@hss.edu

Arthritis Res Ther 2004, 6(Suppl 2):S19-S23 doi:10.1186/ar996

Accesses

Last 30 days: 114 accesses
Last 365 days: 1330 accesses
All time: 9359 accesses

Cited by

BioMed Central: 1 citation

Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period

Juan J Gomez-Reino, Loreto Carmona, Arthritis Research & Therapy 2006, 8:R29 (6 January 2006)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Google Scholar: View citations

PubMed Central: View citations